tradingkey.logo
tradingkey.logo

US FDA approves Novo's insulin injection for type 2 diabetes

ReutersMar 26, 2026 11:52 PM

- The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk NOVOb.CO's insulin injection, Awiqli, to improve blood sugar levels in adults living with type 2 diabetes, the company said on Thursday.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI